Most Recent
A key officer from the ACCC involved in interviewing JPMorgan bankers during a cartel investigation that led to criminal charges against ANZ and two investment banks has denied allegations that he acted improperly during the investigation.
Two biotech companies that provide molecular diagnostic products used in genetic screening will face off in Federal Court over whether one of the company's 'Access' trade mark is likely to confuse consumers.
A sideshow evidentiary dispute in a committal hearing in a landmark criminal cartel case against ANZ and two investment banks has drawn to a close, but not before testing the patience of a magistrate, who warned her ruling would be far from a "Rolls Royce decision".
JPMorgan has taken ANZ to task for its "heroic endeavours to create an air of suspicion" around the conduct of ASIC and the ACCC prior to the filing of a landmark criminal cartel case, slamming the allegations as purely speculative.
ANZ is seeking information on whether the ACCC put pressure on ASIC to not pursue proceedings against JP Morgan over a $2.5 billion share placement that is at the centre of a closely watched criminal cartel case, saying the matter raised a "serious question" about potential abuse of power by the regulators.
A year after Commissioner Kenneth Hayne released his scathing report, companies in the financial services sector are still facing fresh class actions over conduct aired at the banking royal commission, and the pace has even picked up in recent months.
German drug company Fresenius Kadi has resolved a patent case brought by Korean drug company Samsung Bioepis over a biosimilar of top selling arthritis drug Humira.
Hotel booking aggregator Trivago misled consumers about its cheapest price promise by arranging its listings according to payments it received instead of the actual hotel room price, a court has found.
Lawyerly's Litigation Firms of 2019 racked up multiple wins last year in high-stakes litigation against formidable opponents, including the country's top regulators.
The UK-based Scotch Whisky Association has lost its opposition to the Clyde River trade mark for use on alcoholic beverages, with an IP Australia delegate saying the mark had no connection to the production of spirits and rejecting the trade organisation's argument that the mark was evocative of Scotland.